PET/MRI imaging using this radiotracer in a mouse model with an A549 tumor demonstrated high tumor uptake and PD-L1-targeting, providing an excellent opportunity for PD-L1 therapy in patients with lung cancer. This evidence concerns the gene CD274 and neoplasm.